Bengaluru medtech firm Ayati Devices raised Rs 15 crore in a pre-Series A led by Inflexor Ventures, its first institutional round, to expand manufacturing, overseas sales, and AI-enabled diagnostics for diabetic foot and peripheral vascular disease. Founded by Nishant Kathpal and incubated at IIT Bombay's SINE, Ayati sells portable tools such as Vibrasense, Vasosense, and Angiocam so clinics can screen before ulcers and amputations. The company says more than 10,000 devices are deployed across 30-plus countries and cites CDSCO, FDA, and CE clearances. AI is framed as clinician decision support, not replacement. Commercial outcome claims still rest largely on company-reported adoption figures.